BRKR Insider Trading

Insider Ownership Percentage: 27.30%
Insider Buying (Last 12 Months): $5,037,700.00
Insider Selling (Last 12 Months): $0.00

Bruker Insider Trading History Chart

This chart shows the insider buying and selling history at Bruker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal Insider BuyingTotal Insider Selling

Bruker Share Price & Price History

Current Price: $39.66
Price Change: Price Increase of +0.59 (1.51%)
As of 04/28/2025 05:00 PM ET

This chart shows the closing price history over time for BRKR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$39.66Closing price on 04/28/25:

SEC Filings (Institutional Ownership Changes) for Bruker (NASDAQ:BRKR)

79.52% of Bruker stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BRKR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$17Mbought$20MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$500M$0$500MTotal InflowsTotal Outflows
Bruker logo
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Read More on Bruker

Today's Range

Now: $39.66
Low: $38.85
High: $39.97

50 Day Range

MA: $42.99
Low: $35.98
High: $52.92

52 Week Range

Now: $39.66
Low: $34.10
High: $82.04

Volume

1,848,009 shs

Average Volume

1,515,784 shs

Market Capitalization

$6.01 billion

P/E Ratio

52.18

Dividend Yield

0.51%

Beta

1.18

Who are the company insiders with the largest holdings of Bruker?

Bruker's top insider shareholders include:
  1. Frank H Laukien (CEO)
  2. Gerald N Herman (CFO)
  3. Hermann Fritz Requardt (Director)
  4. Thomas Bures (CAO)
Learn More about top insider investors at Bruker.

Who are the major institutional investors of Bruker?

Bruker's top institutional shareholders include:
  1. Pallas Capital Advisors LLC — 6.26%
  2. Vaughan Nelson Investment Management L.P. — 0.50%
  3. Rhumbline Advisers — 0.21%
  4. Allspring Global Investments Holdings LLC — 0.14%
  5. Lawson Kroeker Investment Management Inc. NE — 0.14%
  6. Stanley Laman Group Ltd. — 0.06%
Learn More about top institutional investors of Bruker stock.

Which major investors are selling Bruker stock?

In the last quarter, BRKR stock was sold by these institutional investors:
  1. Vaughan Nelson Investment Management L.P.
  2. Bessemer Group Inc.
  3. State of Alaska Department of Revenue
  4. Envestnet Portfolio Solutions Inc.
  5. Sequoia Financial Advisors LLC
  6. Ferguson Wellman Capital Management Inc.
  7. Rheos Capital Works Inc.
  8. Stanley Laman Group Ltd.

Which major investors are buying Bruker stock?

In the previous quarter, BRKR stock was purchased by institutional investors including:
  1. Lawson Kroeker Investment Management Inc. NE
  2. Lecap Asset Management Ltd.
  3. GAMMA Investing LLC
  4. Washington Capital Management Inc.
  5. Pallas Capital Advisors LLC
  6. Wealth Enhancement Advisory Services LLC
  7. Merit Financial Group LLC
  8. Diversified Trust Co
During the last year, these company insiders have bought Bruker stock:
  1. Frank H Laukien (CEO)
  2. Gerald N Herman (CFO)
Learn More investors buying Bruker stock.